Literature DB >> 20948239

Axial length of myopia: a review of current research.

Weihua Meng1, Jacqueline Butterworth, François Malecaze, Patrick Calvas.   

Abstract

Myopia, or nearsightedness, is a worldwide common type of refractive error. It is a non-life-threatening disorder with huge social and economic consequences due to its increasing prevalence. Axial length (AL) is the primary determinant of non-syndromic myopia. It is a parameter representing the combination of anterior chamber depth, lens thickness and vitreous chamber depth of the eye. AL can also be treated as an endophenotype of myopia and may provide extra advantages in the investigation of its genetic basis. The study of AL will not only identify the determinants of eye elongation, but also provide aetiological evidence for myopia. The purpose of this review is to outline the current state of AL research. Epidemiological evidence, genetic determinants, the relationship with other eye components and relative animal models of AL are summarised.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20948239     DOI: 10.1159/000317072

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  68 in total

1.  Evaluation of biometry and corneal astigmatism in cataract surgery patients in Northern United Arab Emirates.

Authors:  Eui Seok Han; Moonjung Kim
Journal:  Int Ophthalmol       Date:  2019-05-27       Impact factor: 2.031

2.  Association of Myopia With Peripapillary Perfused Capillary Density in Patients With Glaucoma: An Optical Coherence Tomography Angiography Study.

Authors:  Yanin Suwan; Masoud Aghsaei Fard; Lawrence S Geyman; Apichat Tantraworasin; Toco Y Chui; Richard B Rosen; Robert Ritch
Journal:  JAMA Ophthalmol       Date:  2018-05-01       Impact factor: 7.389

3.  Prevalence of corneal astigmatism before cataract surgery.

Authors:  Mehran Mohammadi; Mohammad Naderan; Rozhin Pahlevani; Ali Jahanrad
Journal:  Int Ophthalmol       Date:  2016-02-24       Impact factor: 2.031

4.  Dual band dual focus optical coherence tomography for imaging the whole eye segment.

Authors:  Shanhui Fan; Lin Li; Qian Li; Cuixia Dai; Qiushi Ren; Shuliang Jiao; Chuanqing Zhou
Journal:  Biomed Opt Express       Date:  2015-06-12       Impact factor: 3.732

5.  Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema.

Authors:  António Campos; Elisa J Campos; Anália do Carmo; Miguel Patrício; João P Castro de Sousa; António Francisco Ambrósio; Rufino Silva
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-07-23       Impact factor: 3.117

6.  Identifying characteristic features of the retinal and choroidal vasculature in choroideremia using optical coherence tomography angiography.

Authors:  A Abbouda; A M Dubis; A R Webster; M Moosajee
Journal:  Eye (Lond)       Date:  2017-11-17       Impact factor: 3.775

7.  Reply to letter to the editor: Subfoveal Choroidal Thickness as a Predictor of Treatment Response to Anti-Vascular Endothelial Growth Factor Therapy for Polypoidal Choroidal Vasculopathy.

Authors:  Hyesun Kim; Sung Chul Lee; Kye Yoon Kwon; Christopher Seungkyu Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-26       Impact factor: 3.117

8.  Reply to a letter to the editor: Diabetic Retinal Pigment Epitheliopathy: Fundus Autofluorescence and Spectral-Domain Optical Coherence Tomography Findings.

Authors:  Eui Chun Kang; Yuri Seo; Suk Ho Byeon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-24       Impact factor: 3.117

9.  Assessment of axial length measurements in mouse eyes.

Authors:  Han na Park; Yureeda Qazi; Christopher Tan; Seema B Jabbar; Yang Cao; Gregor Schmid; Machelle T Pardue
Journal:  Optom Vis Sci       Date:  2012-03       Impact factor: 1.973

Review 10.  Changes in axial length after orthokeratology lens treatment for myopia: a meta-analysis.

Authors:  Meng Guan; Weijia Zhao; Yu Geng; Yang Zhang; Jia Ma; Zonghan Chen; Mingqian Peng; Yan Li
Journal:  Int Ophthalmol       Date:  2020-01-08       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.